Search
R-306465
go.drugbank.com/drugs/DB12382InvestigationalR306465 has been used in trials studying the treatment of Neoplasms.
Camicinal
go.drugbank.com/drugs/DB12567InvestigationalCamicinal has been used in trials studying the treatment of Gastroparesis.
RO-4987655
go.drugbank.com/drugs/DB12933InvestigationalRO4987655 has been used in trials studying the treatment of Neoplasms.
Nimustine
go.drugbank.com/drugs/DB13069InvestigationalNimustine has been used in trials studying the treatment of Glioblastoma.
Norvaline
go.drugbank.com/drugs/DB04185InvestigationalNorvaline is an isomer of the more common amino acid valine.
Bacteriochlorophyll A
go.drugbank.com/drugs/DB01853ExperimentalA specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.
Ceramide NP
go.drugbank.com/drugs/DB14111InvestigationalCeramide NP is a lipid molecule included in a group of lipid molecules called ceramides. Ceramides are major lipid components in the stratum corneum of the human skin. … Ceramide 3 consists of a phytosphingosine backbone N-acylated with a saturated fatty acid (stearic acid) [A27233]. It is widely used as a moisturizer in various cosmetic and personal products.
Synonyms: Cer(t18:0/18:1n-9), N-oleoylphytosphingosineMivebresib
go.drugbank.com/drugs/DB21300InvestigationalMivebresib is under investigation in clinical trial NCT04480086 (Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants … The usage of the INN stem '-bresib' in the name indicates that Mivebresib is a inhibitor of the bromodomain and extra-terminal motif (BET) family of bromodomain (BRD) protein, antineoplastic.
Robenacoxib
go.drugbank.com/drugs/DB11455ExperimentalVet approvedRobenacoxib is a non-steroidal anti-inflammatory drug used in veterinary medicine for the relief of pain and inflammation in cats and dogs.
Anetumab ravtansine
go.drugbank.com/drugs/DB14809InvestigationalAnetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).